Annual report [Section 13 and 15(d), not S-K Item 405]

Note 9 - Accrued Liabilities

v3.26.1
Note 9 - Accrued Liabilities
12 Months Ended
Dec. 31, 2025
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]

9.           Accrued Liabilities

 

Accrued liabilities consisted of the following (in thousands):

 

   

December 31,

2025

   

December 31,

2024

 

Compensation

  $ 1,380     $ 1,060  

Clinical trial costs

    1,291       2,277  

Research and development services

    749       888  

Professional services fees

    120       112  

Other

    5       10  

Total accrued liabilities

  $ 3,545     $ 4,347